Q3 EPS Forecast for Verve Therapeutics Lifted by Analyst
Verve Therapeutics, Inc. (NASDAQ:VERV – Free Report) – Stock analysts at William Blair upped their Q3 2025 EPS estimates for shares of Verve Therapeutics in a research note issued on Wednesday, May 14th. William Blair analyst M. Minter now expects that the company will earn ($0.73) per share for the quarter, up from their previous […]
Verve Therapeutics, Inc. (NASDAQ:VERV – Free Report) – Stock analysts at William Blair upped their Q3 2025 EPS estimates for shares of Verve Therapeutics in a research note issued on Wednesday, May 14th. William Blair analyst M. Minter now expects that the company will earn ($0.73) per share for the quarter, up from their previous […]
